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Background: Early and appropriate antibiotic treatment improves the clinical outcome of 
patients with septicemia; therefore, reducing the turn-around time for identification (ID) 
and antimicrobial susceptibility test (AST) results is essential. We established a method for 
rapid ID and AST using short-term incubation of positive blood culture broth samples on 
solid media, and evaluated its performance relative to that of the conventional method us-
ing two rapid ID systems and a rapid AST method.
Methods: A total of 254 mono-microbial samples were included. Positive blood culture 
samples were incubated on blood agar plates for six hours and identified by the MicroFlex 
LT (Bruker Daltonics) and Vitek-MS (bioMeriéux) systems, followed by AST using the Vi-
tek2 System (bioMeriéux).
Results: The correct species-level ID rates were 82.3% (209/254) and 78.3% (199/254) 
for the MicroFlex LT and Vitek-MS platforms, respectively. For the 1,174 microorganism/
antimicrobial agent combinations tested, the rapid AST method showed total concordance 
of 97.8% (1,148/1,174) with the conventional method, with a very major error rate of 0.5%, 
major error rate of 0.7%, and minor error rate of 1.0%. 
Conclusions: Routine implementation of this short-term incubation method could provide 
ID results on the day of blood culture-positivity detection and one day earlier than the con-
ventional AST method. This simple method will be very useful for rapid ID and AST of bac-
teria from positive blood culture bottles in routine clinical practice.
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INTRODUCTION 
Appropriate and timely antimicrobial treatment significantly im-
proves clinical outcomes for patients with sepsis [1]. Therefore, 
reducing the turn-around time of species identification (ID) and 
antimicrobial susceptibility test (AST) results is a high-priority 
topic for clinical microbiologists. The introduction of matrix-as-
sisted laser desorption ionization-time of flight mass spectrome-
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try (MALDI-TOF MS) has allowed pathogen species ID within a 
few minutes, as opposed to the several days required by con-
ventional biochemical methods [2]. Unlike other clinical sam-
ples, positive blood cultures need at least one additional day to 
yield pure bacterial colonies for subsequent tests and procedures. 
Therefore, various blood sample preparation protocols for MALDI-
TOF MS have been developed to remove human cells and pro-
teins from the blood culture broth [3-7]. However, these sample 
preparation methods negate the main advantages of this tech-
nique—convenience and speed—by introducing additional la-
bor-intensive and expensive steps, and this drawback has lim-
ited their application in routine clinical microbiology practice. 
To overcome the drawbacks of the current sample prepara-
tion methods, we developed an easier and cheaper method, 
designated the “short-term incubation method on a solid me-
dium.” This method could eliminate the need for centrifugation 
and additional chemicals to extract bacterial proteins. This pro-
tocol involves a 6-hour incubation of a positive blood culture 
broth with subsequent ID and AST using MALDI-TOF MS and 
automated AST devices. This is the first prospective study to 
evaluate the performance of this short-term incubation method 
for both species ID and AST. This study also compares the per-
formance of two rapid ID platforms using this approach: Micro-
Flex LT (Bruker Daltonics, Bremen, Germany) and Vitek-MS 
(bioMeriéux, Marcy l’Etoile, France).
METHODS 
1. Blood culture samples 
We used blood culture bottles inoculated with blood drawn from 
a peripheral vein that were referred to the laboratory in Sever-
ance hospital, Seoul, Korea, during the period from April to Au-
gust 2014. Any sample with growth of more than one bacterial 
species or yeast was excluded from the study. Among the 334 
blood cultures referred, 254 mono-microbial aerobic samples 
were ultimately identified and included in the study. The BacT/
ALERT® 3D system (bioMeriéux, Marcy l’Etoile, France) was 
used for initial testing of the blood cultures. When a blood cul-
ture bottle showed a positive signal, Gram staining was performed.
Parallel to the conventional workflow shown in Fig. 1, broth 
was collected from the positive blood culture bottles and inocu-
lated on blood agar plates (BAP; Asan Pharmaceutical Co., Ltd., 
Seoul, Korea) and MacConkey agar plates (Becton Dickinson, 
Sparks, MD, USA), followed by incubation at 35°C under 5% 
CO2 atmosphere. One BAP was used for the rapid ID and AST, 
and the others were used for conventional biochemical ID and 
AST. This study was approved by the Institutional Review Board 
of Severance Hospital, Yonsei University Health System (2017-
2648-001). 
2. Conventional workflow of positive blood cultures 
When the BacT/ALERT® 3D System showed a positive signal, 
Gram staining was performed, followed by subculture on an ap-
propriate solid agar medium. Following overnight incubation, 
the colonies grown on the agar plates were used for ID and AST 
using the commercial automated Vitek2 system (bioMeriéux). 
The ID and AST results obtained using this conventional work-
flow were used as the standard for comparison. 
3. Rapid ID and AST using the short-term incubation method
Rapid ID was performed using two MALDI-TOF MS systems: 
MicroFlex LT and Vitek-MS. The Vitek2 system was used for the 
Fig. 1. Workflow of rapid and conventional species identification (ID) and antimicrobial susceptibility test (AST).
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rapid AST. 
Bacterial colonies that grew on the BAP after the 6-hour incu-
bation period were transferred to the MicroFlex LT and Vitek-MS 
target plates using a 1-µL sterile plastic loop. The target plates 
were overlaid with 1 µL of a matrix solution composed of satu-
rated α-cyano-4-hydroxycinnamic acid in 50% acetonitrile/2.5% 
trifluoroacetic acid or with the VitekMS-CHCA matrix solution 
(α-cyano-4-hydroxycinnamic acid solution, ethanol, acetonitrile, 
solvent) for MicroFlex LT or Vitek-MS, respectively. The plates 
were dried in room air and subsequently subjected to MALDI-
TOF MS. The ID process was performed only once for each sam-
ple. Criteria for reliable ID included confidence scores of ≥1.7 
for MicroFlex LT and ≥90% for Vitek-MS [8, 9] according to the 
manufacturers’ guidelines. When Vitek-MS provided more than 
one result with the same genus, we assumed that the result rep-
resented a reliable ID at the genus level. 
To compare the AST results obtained using the rapid AST and 
standard methods, the minimum inhibitory concentrations ob-
tained by both methods were categorized as susceptible, inter-
mediate, or resistant, according to the interpretive criteria of the 
Vitek2 system following the CLSI recommendation [10]. The com-
parison between the rapid and standard methods was classified 
as: agreement, very major error (false susceptibility), major error 
(false resistance), or minor error (susceptible/resistant vs inter-
mediate susceptibility). AST was performed for 232 isolates, which 
could be possible pathogens considering the patients’ clinical 
characteristics.
4. Time to ID
We recorded the turn-around time for both the conventional and 
rapid ID methods from the time of sample registration to result 
reporting through the five-month study duration from April to 
Table 1. Results obtained by the two MALDI-TOF MS systems using the short-term bacterial incubation method compared with those of 
the conventional method
Microorganism N
N (%) identified in MicroFlex N (%) identified in Vitek-MS
Concordance level Non-reliable  
ID
Concordance level Non-reliable  
IDSpecies Genus Species Genus
Gram-positive bacteria 143 110 (76.9) 116 (81.1) 28 (19.6)  105 (73.4) 110 (76.9) 33 (23.1)
Gram-positive cocci 120 100 (83.3) 106 (88.3) 15 (12.5) 96 (80.0) 101 (84.2) 19 (15.8)
   Staphylococcus aureus 14  14 (100) 14 (100) 0 (0.0)  14 (100) 14 (100) 0 (0.0)
   Coagulase-negative staphylococci* 60  52 (86.7) 53 (88.3) 7 (11.7)  47 (78.3) 48 (80.0) 11 (18.3)
   Enterococci 25  24 (96.0) 24 (96.0) 1 (4.0)  24 (96.0) 24 (96.0) 1 (4.0)
      Enterococcus faecalis 12  12 (100) 12 (100) 0 (0.0)  12 (100) 12 (100) 0 (0.0)
      Enterococcus faecium 13  12 (92.3) 12 (92.3) 1 (7.6)  12 (92.3) 12 (92.3) 1 (7.6)
   Streptococci† 19  10 (52.6) 14 (73.7) 7 (36.8)  11 (57.9) 14 (73.7) 6 (31.6)
Other‡ 2  1 (50.0) 1 (50.0) 1 (50.0)  1 (50.0) 1 (50.0) 1 (50.0)
Gram-positive rods§ 23  10 (43.5) 10 (43.5) 13 (56.5)  9 (39.1) 9 (39.1) 14 (60.9)
Gram-negative bacteria 111  99 (89.2) 106 (95.5) 5 (4.5)  94 (84.7) 100 (90.9) 11 (9.9)
Enterobacteriaceae 94  85 (90.4) 90 (95.7) 4 (4.3)  79 (84.0) 85 (90.4) 9 (9.6)
   Escherichia coli 53  52 (98.1) 52 (98.1) 1 (1.9)  51 (96.2) 51 (96.2) 2 (3.8)
   Klebsiella pneumoniae 22  20 (90.9) 20 (90.9) 2 (9.1)  17 (77.3) 17 (77.3) 5 (22.7)
   Other Enterobacteriaceae|| 19 13 (68.4) 18 (94.7) 1 (5.3) 11 (57.8) 17 (89.4) 2 (10.5)
Glucose non-fermenters¶ 11  9 (81.8) 10 (90.9) 1 (9.1)  10 (90.9) 10 (90.9) 1 (9.1)
Other Gram-negative bacteria** 6  5 (83.3) 6 (100) 0 (0.0)  5 (83.3) 5 (83.3) 1 (16.7)
Total 254  209 (82.3) 222 (87.4) 33 (13.0)  199 (78.3) 210 (86.6) 44 (17.3)
*Coagulase-negative staphylococci: S. epidermidis, S. hominis, S. haemolyticus, S. capitis, S. auricularis, S. saprophyticus, S. warne.r; †Streptococci: S. pyo-
genes, S. agalactiae, S. anginosus, S. constellatus, S. intermedius, S. salivarius, S. pluranimalium, S. equisimilis, S. pneumoniae, S. mitis, S. parasanguinis, 
S. sanguis; ‡Other: Granulicatella adiacens; §Gram-positive rods: Bacillus spp., diphtheroids, Clostridium septicum, Arthrobacter spp., Listeria monocyto-
genes; ||Other Enterobacteriaceae: Enterobacter cloacae, Enterobacter asburiae, Enterobacter aerogenes, Citrobacter freundii, Citrobacter braakii, Morganella 
morganii, Salmonella spp., Proteus mirabilis; ¶Glucose non-fermenters: Acinetobacter baumannii, Acinetobacter lwoffii, Acinetobacter radioresistens, Pseu-
domonas aeruginosa, Stenotrophomonas maltophilia; **Other Gram-negative bacteria: Burkholderia cepacia, Aeromonas caviae, Bacteroides caccae, My-
roides spp., Ochrobactrum anthropic.
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August 2014. The mean difference was calculated based on re-
cords from the laboratory information system.
5. Statistical analysis
Chi-square test was used to compare proportions. Statistical anal-
yses were performed using a software package (Analyse-it, ver-
sion 3.90.7). A P value less than 0.05 was considered statisti-
cally significant.
RESULTS
1. Comparison of rapid and conventional ID results
The concordance of the species-level ID results obtained using 
MicroFlex LT and Vitek-MS with those obtained using the con-
ventional biochemical ID method (Vitek2 system) was 82.3% 
(209/254) and 78.3% (199/254), respectively (Table 1, see 
Supplemental Data Table S1). The concordance rates for Gram 
positive bacteria were 76.9% (110/143) and 73.4% (105/143) 
and the rates for Gram-negative bacteria were 89.2% (99/111) 
and 84.7% (94/111) for the MicroFlex LT and Vitek-MS sys-
tems, respectively.
Table 1 also shows the percentages of non-reliable results, 
which were slightly higher for the Vitek-MS system than for the 
MicroFlex system, but the difference was not statistically signifi-
cant (P =0.174). In addition, the non-reliable ID percentage was 
greater for Gram-positive isolates than for Gram-negative bacte-
ria with both systems. Considering only the reliable ID results, 
the species-level concordance rates were more than 94% and 
Table 2. Antimicrobial susceptibility test results for the short-term incubation method compared with those of the conventional method
Microorganism (N of ASTs conducted)
N (%) of
Agreement Minor error Major error Very major error
Gram-positive bacteria (517) 509 (98.5) 3 (0.6) 3 (0.6) 2 (0.4)
Staphylococci (368) 364 (98.9)
   S. aureus (80) 80 (100)
   S. epidermidis (128) 126 (98.4) One with teicoplanin,  
one with ciprofloxacin
   S. hominis (96) 94 (97.9) One with cotrimoxazole One with cotrimoxazole
   S. haemolyticus (16) 16 (100)
   S. capitis (32) 32 (100)
   S. auricularis (16) 16 (100)
Enterococci (806) 785 (97.4)
   E. faecium (65) 64 (98.5) One with nitrofurantoin
   E. faecalis (84) 81 (96.4) One with penicillin G,  
one with gentamicin
One with vancomycin
Gram-negative bacteria (657) 639 (97.3) 9 (1.4) 5 (0.8) 4 (0.6)
Enterobacteriaceae (608) 590 (97.0)
   Escherichia coli (288) 275 (95.5) Five with cefepime, one with 
ampicillin-sulbactam, one 
with meropenem
One with ampicillin-sulbactam,  
one with gentamicin, one with 
cotrimoxazole, one with aztreonam
One with ceftazidime,  
one with ertapenem
   Klebsiella pneumoniae (160) 159 (99.4) One with aztreonam
   Enterobacter cloacae (112) 109 (100) Two with ertapenem One with meropenem
   Enterobacter asburiae (16) 16 (100)
   Citrobacter freundii (16) 16 (100)
   Citrobacter braakii (16) 15 (93.8) One with amikacin
Glucose non-fermenters (49) 49 (100)
   Acinetobacter baumannii (16) 16 (100)
   Acinetobacter radioresistens (17) 17 (100)
   Pseudomonas aeruginosa (16) 16 (100)
Total (1,174) 1,148 (97.8) 12 (1.0) 8 (0.7) 6 (0.5)
Abbreviation: AST, antimicrobial susceptibility test.
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were similar for both systems. However, the concordance rates 
for streptococci (n=19) were considerably low for both systems. 
2. Comparison of rapid and conventional AST results
Among the 254 isolates from the positive blood culture bottles, 
the AST results of 232 isolates showed clinical significance and 
were included in the analysis. As shown in Table 2, the rapid 
AST results exhibited very high concordance (>97%) with those 
of the conventional method, with a low error rate (<1.0%). The 
concordance rate was slightly higher for Gram-positive isolates 
(n=517) than for Gram-negative isolates (n=657), and the er-
ror rates were slightly lower in the former group. Interestingly, 
errors in Escherichia coli AST accounted for 72.2% (13/18) of 
the total error observed for Gram-negative isolates (Table 2).
3. Time to identification
The mean turn-around time for the conventional method over 
the five-month period was 5,691 minutes (3.95 days), whereas 
the rapid ID approach using the new short-term incubation 
method produced results in 3,722 minutes (2.58 days), repre-
senting a mean difference of 1,366 minutes (1.37 days). 
DISCUSSION
The aim of the present study was to evaluate the performance 
of a short-term incubation method for identifying bacterial patho-
gens from blood culture for both ID and AST, and to compare its 
results with those by the MicroFlex LT and Vitek-MS systems. 
Bacteremia results in a high crude (24%) and attributable 
(17%) mortality rate [11]; therefore, appropriate and timely anti-
microbial treatment is crucial for improving the clinical outcomes 
of the patients with bacteremia [1]. To eliminate the time-con-
suming step of conventional blood culture processing, several 
approaches, including MALDI-TOF MS, have been evaluated for 
achieving rapid pathogen ID from a positive blood culture broth 
[12, 13]. However, the complicated sample handling steps have 
hampered the widespread usage of MALDI-TOF MS in routine 
blood culture practice. To overcome this limitation, several meth-
ods for preparation of blood culture broth have been introduced 
to enable the direct identification of bacteria in positive blood 
culture bottles, such as lysis-filtration [3], lysis extraction [4], 
protein extraction [5], red blood cell lysis [6], and modified lysis 
with nylon mesh [7]. These methods could provide a positive ID 
for 91.4–99% of Gram-negative isolates and for 67.7–97% of 
Gram-positive isolates in about 15–45 minutes. However, all 
these methods require special reagents and a centrifugation 
process. In the short-term incubation method developed in this 
study, the additional preparatory steps are minimized to the 
preparation of one BAP for one drop of a sample. 
Although this proposed rapid ID and AST method has proven 
to be a very powerful and simple tool, there are some drawbacks 
that need to be overcome [14, 15]. According to Kohlmann et al 
[14], rapid ID results obtained using this method allowed for op-
timized treatment to be recommended in 51.1% of cases, whereas 
only 26.4% of the Gram stain results allowed for proper treat-
ment. Zebbe et al [15] reported that 77% of bacteria were cor-
rectly identified with only a three-hour incubation of one drop 
from a positive blood culture bottle on a chocolate agar plate. 
Similar results were obtained in our study, in that the concor-
dance rate was higher in Gram-negative isolates than in Gram-
positive isolates. The higher percentage of non-reliable IDs in 
Gram-positive isolates could have resulted from the relatively 
less growth of these organisms after the six-hour incubation. 
We incubated the subculture plates for six hours because this 
was previously shown to substantially increase the species-level 
ID concordance rate of the short-term incubation method to 
90.9% (159/175) from 80.6% (141/175) obtained using a four-
hour incubation period [16]. One study showed that the incuba-
tion time could be shortened by 3–6 hours using pre-warmed 
chocolate agar to obtain a similar correct identification rate [17]. 
However, that study used a pellet streak, which requires an ad-
ditional centrifugation step to obtain the pellet from the blood 
culture broths. We did not adopt this process because this 
could represent a hurdle for routine practice.
Interestingly, most of the results that were discordant between 
MALDI-TOF MS and the conventional ID method were due to 
non-reliable results rather than misidentifications. Therefore, when 
samples with non-reliable results were excluded, very high con-
cordance rates for species-level ID were obtained: 94.6% (209/ 
221) for MicroFlex LT and 94.8% (199/210) for Vitek-MS. Sur-
prisingly, low concordance rates of 52.6% (10/19) and 57.9% 
(11/19) were obtained for Streptococcus spp. with the Micro-
Flex LT and Vitek-MS platforms, respectively. This finding is in 
contrast with previous data, as summarized in a review article 
[18]. The cause of this discrepancy might be the difference in 
incubation times or, possibly, the lack of optimal conditions for 
the growth of streptococci on BAPs, which could result in a fail-
ure to produce sufficient proteins for accurate MALDI-TOF MS 
analysis. However, given the small number of streptococci iso-
lates in this study, the results for streptococcal species identifi-
cation might be considered preliminary when specifically using 
the short-term incubation method on a solid medium presented 
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herein.
Regarding the applications of this rapid procedure for AST, 
the error rate was not substantial, with 1.0% minor error, 0.7% 
major error, and 0.5% very major error; the results were within 
the <3% and <1.5% US Food and Drug Administration (FDA) 
limits for major and very major errors, respectively [19]. The AST 
results for E. coli showed the largest number of discordances, 
which is likely due to the fact that the number of antimicrobials 
tested in E. coli (average, 275) was much higher than that tested 
for the other species (average, 68). Despite this higher rate of 
discordance, the major and very major error rates (1.4% [4/288] 
and 0.7% [2/288], respectively) for E. coli were still within the 
FDA limits. According to the comparison of all AST results, the 
concordance rates between the conventional AST methods and 
the short-term incubation method presented herein were very 
high.
One possible limitation of this study is the restricted spectrum 
of bacterial species analyzed, which was due to the limited sam-
ple size obtained from a clinical microbiology laboratory. Thus, 
these results might not apply to other laboratories. Further study 
using a larger number of more diverse samples over a longer 
period is therefore warranted to validate these results. 
In conclusion, the short-term incubation on solid medium 
method for positive blood cultures shows acceptable perfor-
mance for routine ID and AST, especially in clinically relevant 
bacteria. This simple and rapid method could facilitate the im-
plementation of rapid ID and AST into the routine workflow of 
clinical microbiology laboratories, which could improve patient 
outcomes. 
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